Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACTIVATED KILLER CELLS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1082 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lang, S; Zeidler, R; Pauli, C; Andratschke, M; Wollenberg, B
      Targeting head and neck cancer by IL-2-mediated gene therapy: From bench to bedside - A review.

      LARYNGO-RHINO-OTOLOGIE
    2. Pappo, I; Lotem, M; Klein, M; Orda, R
      Bolus high dose interleukin-2 for the treatment of malignant melanoma

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    3. Ohteki, T; Suzue, K; Maki, C; Ota, T; Koyasu, S
      Critical role of IL-15-IL-15R for antigen-presenting cell functions in theinnate immune response

      NATURE IMMUNOLOGY
    4. Grasso, M; Torelli, F; Scannapieco, G; Franzoso, F; Lania, C
      Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2

      JOURNAL OF IMMUNOTHERAPY
    5. Bankert, RB; Egilmez, NK; Hess, SD
      Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies

      TRENDS IN IMMUNOLOGY
    6. Atkins, MB; Dutcher, J; Weiss, G; Margolin, K; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials

      MEDICAL ONCOLOGY
    7. Dutcher, J; Atkins, MB; Margolin, K; Weiss, G; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part II: Management of IL-2 toxicity and studies with other cytokines

      MEDICAL ONCOLOGY
    8. van West, D; Maes, M
      Neuroendocrine and immune aspects of fibromyalgia

      BIODRUGS
    9. Alvarnas, JC; Linn, YC; Hope, EG; Negrin, RS
      Expansion of cytotoxic CD3(+)CD56(+) cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    10. Buzaid, AC; Atkins, M
      Practical guidelines for the management of biochemotherapy-related toxicity in melanoma

      CLINICAL CANCER RESEARCH
    11. Holden, SA; Lan, Y; Pardo, AM; Wesolowski, JS; Gillies, SD
      Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents

      CLINICAL CANCER RESEARCH
    12. Waldmann, TA; Dubois, S; Tagaya, Y
      Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy

      IMMUNITY
    13. Airoldi, M; De Stefani, A; Marchionatti, S; Pedani, F; Gabriele, P; Ragona, R; Cortesina, G; Bumma, C
      Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    14. Kaufman, HL; DeRaffele, G; Divito, J; Horig, H; Lee, D; Panicali, D; Voulo, M
      A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma

      HUMAN GENE THERAPY
    15. Huang, YW; Hayes, RL; Wertheim, S; Arbit, E; Scheff, R
      Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    16. Hayes, RL; Arbit, E; Odaimi, M; Pannullo, S; Scheff, R; Kravchinskiy, D; Zaroulis, C
      Adoptive cellular immunotherapy for the treatment of malignant gliomas

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    17. Cohen, PA; Peng, LM; Kjaergaard, J; Plautz, GE; Finke, JH; Koski, GK; Czerniecki, BJ; Shu, SY
      T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance

      CRITICAL REVIEWS IN IMMUNOLOGY
    18. Minami, K; Yamaguchi, Y; Yoshida, K; Quan, CP; Toge, T
      Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: Possible involvement in cancer-associated immunosuppression mechanism

      ONCOLOGY REPORTS
    19. Rosenberg, SA
      Progress in the development of immunotherapy for the treatment of patientswith cancer

      JOURNAL OF INTERNAL MEDICINE
    20. Phan, GQ; Attia, P; Steinberg, SM; White, DE; Rosenberg, SA
      Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    21. Heinzer, H; Huland, E; Huland, H
      Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer

      WORLD JOURNAL OF UROLOGY
    22. Kobayashi, H; Tanaka, Y; Yagi, J; Toma, H; Uchiyama, T
      Gamma/delta T cells provide innate immunity against renal cell carcinoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    23. He, L; Feng, HP; Raymond, A; Kreeger, M; Zeng, Y; Graner, M; Whitesell, L; Katsanis, E
      Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    24. Al-Atrash, G; Kitson, RP; Xue, YM; Mazar, AP; Kim, MH; Goldfarb, RH
      uPA and uPAR contribute to NK cell invasion through the extracellular matrix

      ANTICANCER RESEARCH
    25. Yamaguchi, Y; Ohta, K; Shimizu, K; Minami, K; Noma, K; Hihara, J; Toge, T
      Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2

      ANTICANCER RESEARCH
    26. Lathers, DMR; Clark, JI; Achille, NJ; Young, MRI
      Phase IB study of 25-hydroxyvitamin D-3 treatment to diminish suppressor cells in head and neck cancer patients

      HUMAN IMMUNOLOGY
    27. Stassar, MJJG; Raddrizzani, L; Hammer, J; Zoller, M
      T-helper cell-response to MHC class II-binding peptides of the renal cell carcinoma-associated antigen RAGE-1

      IMMUNOBIOLOGY
    28. Wroblewski, JM; Bixby, DL; Borowski, C; Yannelli, JR
      Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens

      LUNG CANCER
    29. Castagneto, B; Zai, S; Mutti, L; Lazzaro, A; Ridolfi, R; Piccolini, E; Ardizzoni, A; Fumagalli, L; Valsuani, G; Botta, M
      Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion - Results of a phase II study on 31 consecutive patients

      LUNG CANCER
    30. Bellinger, DL; Felten, DL; Lorton, D; Brouxhon, S
      Effects of interleukin-2 on the expression of corticotropin-releasing hormone in nerves and lymphoid cells in secondary lymphoid organs from the Fischer 344 rat

      JOURNAL OF NEUROIMMUNOLOGY
    31. Li, GX; Lillehoj, HS; Min, WG
      Production and characterization of monoclonal antibodies reactive with thechicken interleukin-15 receptor alpha chain

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    32. Lillehoj, HS; Min, WG; Choi, KD; Babu, US; Bumside, J; Miyamoto, T; Rosenthal, BM; Lillehoj, EP
      Molecular, cellular, and functional characterization of chicken cytokines homologous to mammalian IL-15 and IL-2

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    33. Kintzel, PE
      Anticancer drug-induced kidney disorders - Incidence, prevention and management

      DRUG SAFETY
    34. Mieijer, SL; Dols, A; Hu, HM; Jensen, S; Poehlein, CH; Chu, Y; Winter, H; Yamada, J; Moudgil, T; Wood, WJ; Doran, T; Justice, L; Fisher, B; Wisner, P; Wood, J; Vetto, JT; Mehrotra, R; Rosenheim, S; Weinberg, AD; Bright, R; Walker, E; Puri, R; Smith, JW; Urba, WJ; Fox, BA
      Immunological and molecular analysis of the sentinel lymph node: A potential approach to predict outcome, tailor therapy, and optimize parameters fortumor vaccine development

      JOURNAL OF CLINICAL PHARMACOLOGY
    35. Clarke, R; Leonessa, F; Welch, JN; Skaar, TC
      Cellular and molecular pharmacology of antiestrogen action and resistance

      PHARMACOLOGICAL REVIEWS
    36. Malaguarnera, M; Ferlito, L; Gulizia, G; Di Fazio, I; Pistone, G
      Use of interleukin-2 in advanced renal carcinoma: meta-analysis and reviewof the literature

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    37. Elias, L; Hunt, WC
      A literature analysis of prognostic factors for response and quality of response of patients with renal cell carcinoma to interleukin-2-based therapy

      ONCOLOGY
    38. Chi, KH; Myers, JN; Chow, KC; Chan, WK; Tsang, YW; Chao, Y; Yen, SH
      Phase II trial of systemic recombinant interleukin-2 in the treatment of refractory nasopharyngeal carcinoma

      ONCOLOGY
    39. Flanigan, RC; Salmon, SE; Blumenstein, BA; Bearman, SI; Roy, V; McGrath, PC; Caton, JR; Munshi, N; Crawford, ED
      Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

      NEW ENGLAND JOURNAL OF MEDICINE
    40. Rosenberg, SA
      Progress in human tumour immunology and immunotherapy

      NATURE
    41. Deshmukh, P; Glick, RP; Lichtor, T; Moser, R; Cohen, EP
      Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice

      JOURNAL OF NEUROSURGERY
    42. Bulanova, E; Budagian, V; Pohl, T; Krause, H; Durkop, H; Paus, R; Bulfone-Paus, S
      The IL-15R alpha chain signals through association with Syk in human B cells

      JOURNAL OF IMMUNOLOGY
    43. Abe, Y; Matsumoto, S; Wei, SM; Nezu, K; Miyoshi, A; Kito, K; Ueda, N; Shigemoto, K; Hitsumoto, Y; Nikawa, J
      Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, andthe testes

      JOURNAL OF BIOLOGICAL CHEMISTRY
    44. Nishiyama, R; Sakaguchi, T; Kinugasa, T; Gu, XB; MacDermott, RP; Podolsky, DK; Reinecker, HC
      Interleukin-2 receptor beta subunit-dependent and -independent regulation of intestinal epithelial tight junctions

      JOURNAL OF BIOLOGICAL CHEMISTRY
    45. Masuda, A; Matsuguchi, T; Yamaki, K; Hayakawa, T; Yoshikai, Y
      Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-x(L) expression

      JOURNAL OF BIOLOGICAL CHEMISTRY
    46. Sekine, K; Fujii, H; Abe, F; Nishikawa, K
      Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines

      INTERNATIONAL JOURNAL OF CANCER
    47. Pizza, G; De Vinci, C; Lo Conte, G; Maver, P; Dragoni, E; Aiello, E; Fornarola, V; Bergami, T; Busutti, L; Boriani, S; Palareti, A; Capanna, R
      Immunotherapy of metastatic kidney cancer

      INTERNATIONAL JOURNAL OF CANCER
    48. Buzio, C; Andrulli, S; Santi, R; Pavone, L; Passalacqua, R; Potenzoni, D; Ferrozzi, F; Giacosa, R; Vaglio, A
      Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma

      CANCER
    49. Bay, JO; Choufi, B; Tournilhac, O; Faucher, C; Blaise, D
      Allogeneic hematopoietic cell transplantation in solid tumors

      BULLETIN DU CANCER
    50. Ravaud, A
      Cell therapy for solid tumors

      BULLETIN DU CANCER
    51. Melder, RJ; Kristensen, CA; Munn, LL; Jain, RK
      Modulation of A-NK cell rigidity: In vitro characterization and in vivo implications for cell delivery

      BIORHEOLOGY
    52. Alileche, A; Goldman, CK; Waldmann, TA
      Differential effects of IL-2 and IL-15 on expression of IL-2 receptor alpha

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    53. Boni, LT; Batenjany, MM; Neville, ME; Guo, YQ; Xu, L; Wu, FJ; Mason, JT; Robb, RJ; Popescu, MC
      Interleukin-2-induced small unilamellar vesicle coalescence

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    54. Braun, SW; Gerhartz, HH; Schmetzer, HM
      Influence of cytokines and autologous lymphokine-activated killer cells onleukemic bone marrow cells and colonies in AML

      ACTA HAEMATOLOGICA
    55. Marroquin, CE; White, DE; Steinberg, SM; Rosenberg, SA; Schwartzentruber, DJ
      Decreased tolerance to interleukin-2 with repeated courses of therapy in patients with metastatic melanoma or renal cell cancer

      JOURNAL OF IMMUNOTHERAPY
    56. Fischer, B; Muller, B; Fisch, P; Kreutz, W
      An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: Implications for cancer immunotherapy

      JOURNAL OF IMMUNOTHERAPY
    57. deMagalhaes-Silverman, M; Donnenberg, A; Lembersky, B; Elder, E; Lister, J; Rybka, W; Whiteside, T; Ball, E
      Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer

      JOURNAL OF IMMUNOTHERAPY
    58. Lee, JH; Klein, HG
      From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    59. Tio, RA; Nieken, J; de Vries, EGE; Pfeiffer, C; de Jongste, MJL; Pieper, E; Moshage, H; Limburg, PC; Mulder, NH
      Negative inotropic effects of recombinant interleukin 2 in patients without left ventricular dysfunction

      EUROPEAN JOURNAL OF HEART FAILURE
    60. Tagawa, M
      Cytokine therapy for cancer

      CURRENT PHARMACEUTICAL DESIGN
    61. Mekhail, T; Wood, L; Bukowski, R
      Interleukin-2 in cancer therapy - Uses and optimum management of adverse effects

      BIODRUGS
    62. Lehours, P; Raher, S; Dubois, S; Guo, J; Godard, A; Jacques, Y
      Subunit structure of the high and low affinity human interleukin-15 receptors

      EUROPEAN CYTOKINE NETWORK
    63. Blaise, D; Attal, M; Reiffers, J; Michallet, M; Bellanger, C; Pico, JL; Stoppa, AM; Payen, C; Marit, G; Bouabdallah, R; Sotto, JJ; Rossi, JF; Brandely, M; Hercend, T; Maraninchi, D
      Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission

      EUROPEAN CYTOKINE NETWORK
    64. Frost, P; Bonavida, B
      Circumvention of tumor cell escape following specific immunotherapy

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    65. Fisher, RI; Rosenberg, SA; Fyfe, G
      Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    66. Vuky, J; Motzer, RJ
      Cytokine therapy in renal cell cancer

      UROLOGIC ONCOLOGY
    67. Visonneau, S; Cesano, A; Porter, DL; Luger, SL; Schuchter, L; Kamoun, M; Torosian, MH; Duffy, K; Sickles, C; Stadtmauer, EA; Santoli, D
      Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer

      CLINICAL CANCER RESEARCH
    68. Kaplan, B; Moy, RL
      Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma

      DERMATOLOGIC SURGERY
    69. Bohle, A; Thanhauser, A; Ernst, M; Flad, HD; Rusch-Gerdes, S; Jocham, D; Ulmer, AJ
      Reduction of side effects of intravesical therapy with bacille Calmette-Guerin by pentoxifylline? An in vitro approach

      CLINICAL INFECTIOUS DISEASES
    70. Knupfer, MM; Knupfer, H; Van Gool, S; Domula, M; Wolff, JEA
      Interferon gamma inhibits proliferation and hyaluronic acid adhesion of human malignant glioma cells in vitro

      CYTOKINE
    71. Cohen, PA; Peng, LM; Plautz, GE; Kim, JA; Weng, DE; Shu, SY
      CD4(+) T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection

      CRITICAL REVIEWS IN IMMUNOLOGY
    72. Toge, T; Yamaguchi, Y
      Protein-bound polysaccharide increases survival in resected gastric cancercases stratified with a preoperative granulocyte and lymphocyte count

      ONCOLOGY REPORTS
    73. Suzuki, M; Kimura, H; Iwai, N; Fujisawa, T
      Intermittent adjuvant chemo-immunotherapy after resection of non-small cell lung cancer with multilevel mediastinal lymph node metastasis

      ONCOLOGY REPORTS
    74. Huang, GTJ; Zhang, XL; Park, NH
      Increased ICAM-1 expression in transformed human oral epithelial cells: molecular mechanism and functional role in peripheral blood mononuclear cell adhesion and lymphokine-activated-killer cell cytotoxicity

      INTERNATIONAL JOURNAL OF ONCOLOGY
    75. Schendel, DJ; Falk, CS; Nossner, E; Maget, B; Kressenstein, S; Urlinger, S; Tampe, R; Gansbacher, B
      Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognitionbut suppresses non-MHC-restricted effector cell activity

      GENE THERAPY
    76. Paciucci, PA; Ryder, JS; Mandeli, JP; Morris, JC; Holland, JF
      Interleukin-2 plus chemotherapy for patients with metastatic melanoma

      MELANOMA RESEARCH
    77. Bernengo, MG; Quaglino, P; Cappello, N; Lisa, F; Osella-Abate, S; Fierro, MT
      Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients

      MELANOMA RESEARCH
    78. Skubitz, KM; Anderson, PM
      Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial

      ANTI-CANCER DRUGS
    79. Moller, P; Moller, H; Sun, YS; Dorbic, T; Henz, BM; Wittig, B; Schadendorf, D
      Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells

      CANCER GENE THERAPY
    80. Thiele, J; Kvasnicka, HM; Schmitt-Graeff, A
      Therapy-related changes of CD20(+) and CD45RO(+) lymphocyte subsets in chronic myeloid leukemia (CML): An immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow

      MODERN PATHOLOGY
    81. Yaniv, I
      Lymphokines post autologous peripheral blood stem cell transplantation in children

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    82. Vlk, V; Eckschlager, T; Kavan, P; Kabickova, E; Koutecky, J; Sobota, V; Bubenik, J; Pospisilova, D
      Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    83. To, WC; Wood, BG; Krauss, JC; Strome, M; Esclamado, RM; Lavertu, P; Dasko, D; Kim, JA; Plautz, GE; Leff, BE; Smith, V; Sandstrom-Wakeling, K; Shu, SY
      Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck - A phase 1 study

      ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    84. Weynants, P
      Immunity and lung cancer: perspectives for an antitumor vaccine

      REVUE DES MALADIES RESPIRATOIRES
    85. Fong, TC; Sauter, SL; Ibanez, CE; Sheridan, PL; Jolly, DJ
      The use and development of retroviral vectors to deliver cytokine genes for cancer therapy

      CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
    86. Motzer, RJ; Mazumdar, M; Bacik, J; Russo, P; Berg, WJ; Metz, EM
      Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    87. Lindsey, KR; Rosenberg, SA; Sherry, RM
      Impact of the number of treatment courses on the clinical response of patients who receive high-dose bolus interleukin-2

      JOURNAL OF CLINICAL ONCOLOGY
    88. Capuron, L; Ravaud, A; Dantzer, R
      Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy

      JOURNAL OF CLINICAL ONCOLOGY
    89. Sashchenko, LP; Dukhanina, EA; Ioudinkova, ES; Iarovaia, OV; Lukianova, TI; Kabanova, OD; Gnuchev, NV; Razin, SV
      Nonlymphoid cultured cells possess a system controlling cellular compatibility

      JOURNAL OF CELLULAR BIOCHEMISTRY
    90. Verma, V; Sharma, V; Shrivastava, SK; Nadkarni, JJ
      IL-12 acid IL-2 potentiate the in vitro tumor-specific activity of peripheral blood cells from cervical cancer patients

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    91. Kawamura, A; Sekine, T; Sekiguchi, M; Yanoma, S; Kaneko, A; Haneda, T; Moriya, Y; Hayasaka, K; Kakizoe, T
      Six-year disease-free survival of a patient with metastatic eyelid squamous cell carcinoma and colon adenocarcinoma after repeated postoperative adoptive immunotherapy

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    92. Ueno, T; Ohtawa, K; Kimoto, Y; Sakurai, K; Kodera, Y; Hiroto, M; Matsushima, A; Nishimura, H; Inada, Y
      Polyethylene glycol-modified concanavalin A as an effective agent to stimulate anti-tumor cytotoxicity

      CANCER DETECTION AND PREVENTION
    93. Thomas, ML; Samant, UC; Deshpande, RK; Chiplunkar, SV
      gamma delta T cells lyse autologous and allogenic oesophageal tumours: involvement of heat-shock proteins in the tumour cell lysis

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    94. Vasey, PA
      Immunotherapy for renal carcinoma: theoretical basis and current standard of care

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    95. Bohle, A
      BCG's mechanism of action - Increasing our understanding

      EUROPEAN UROLOGY
    96. Rohde, D; Wiesner, C; Graf, D; Wolff, J; Fuzesi, L; Jakse, G
      Interstitial fluid pressure is increased in renal cell carcinoma xenografts

      UROLOGICAL RESEARCH
    97. Oleksowicz, L; Escott, P; Leichman, GC; Spangenthal, E
      Sustained ventricular tachycardia and its successful prophylaxis during high-dose bolus interleukin-2 therapy for metastatic renal cell carcinoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    98. Gravis, G; Viens, P; Vey, N; Blaise, D; Stoppa, AM; Olive, D; Maraninchi, D
      Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers

      ANTICANCER RESEARCH
    99. Nio, Y; Hirahara, N; Minari, Y; Iguchi, C; Yamasawa, K; Toga, T; Tamura, K
      Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface

      ANTICANCER RESEARCH
    100. Bartholeyns, J; Bardot, V; Chokri, M; Romet-Lemonne, JL
      Adoptive immunotherapy: present status and perspectives in cancer treatment.

      REVUE DE MEDECINE INTERNE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 14:19:56